logo color s and clearside.jpg
Clearside Biomedical to Participate in Panel Discussion at the Cantor Global Healthcare Conference
September 19, 2023 07:05 ET | Clearside Biomedical, Inc.
ALPHARETTA, Ga., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through...
Global Corneal Implants Market
Innovative Product Launches such as Biodegradable Implants Transforming the Global Corneal Implants Market; Revenues Projected to Hit $1.65 Billion by 2027
September 19, 2023 05:03 ET | Research and Markets
Dublin, Sept. 19, 2023 (GLOBE NEWSWIRE) -- The "Corneal Implants Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global corneal implants market is on a...
AiViva Biopharma Appoints Lester J. Kaplan, PhD to the Board of Directors
September 18, 2023 06:00 ET | AiViva Biopharma
COSTA MESA, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- AiViva Biopharma Inc., a clinical-stage biotechnology company developing innovative therapies to address major unmet medical needs, today...
RetinalGeniX Logo Revised Sept 2023.jpg
RetinalGeniX Technologies Inc. Focuses on Prevention of Blindness and Early Detection of Multiple Systemic Diseases
September 18, 2023 05:59 ET | RetinalGeniX Technologies, Inc.
PETALUMA, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX Technologies Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”) released to the public via OTC Markets, a video webinar regarding...
ocugen_4C_LOGO (002).png
Ocugen Announces Positive Clinical Study Update from the Phase 1/2 Trial of OCU400, a Modifier Gene Therapy Product Candidate, for the Treatment of Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA)
September 13, 2023 08:15 ET | Ocugen
Favorable safety and tolerability profile of OCU400 investigational drug product in RP and LCA subjects to dateClinical study update suggests continued positive trends in Best-Corrected Visual Acuity...
Pupillometer Market to hit USD 706 million by 2032, says Global Market Insights Inc.
September 12, 2023 20:15 ET | Global Market Insights Inc.
Selbyville, Delaware, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Pupillometer Market size is expected to be worth USD 706 million by 2032. Surging importance in research studies and clinical trials for...
Future Market Insights.png
Placental Growth Factors Market Growth 2023 along with Business Insights and Forecast to 2033
September 06, 2023 11:30 ET | Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Sept. 06, 2023 (GLOBE NEWSWIRE) -- In 2023, the placental growth factors market is expected to be worth US$ 34.9 million. The market is expected to reach US$ 64.6 million by 2033,...
Strategies for Navigating Economic Uncertainties and Transformative Trends in the Fundus Cameras Market
September 06, 2023 08:13 ET | Research and Markets
Dublin, Sept. 06, 2023 (GLOBE NEWSWIRE) -- The "Global Fundus Cameras Market by Product, End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Forecast 2023-2030"...
Optic Neuritis Treatment Market Optic Neuritis Treatment Market Growth Rate By Region
Steroidal Therapy Segment Soars as Optic Neuritis Treatment Market Expands 2023 to 2028
September 04, 2023 07:03 ET | Research and Markets
Dublin, Sept. 04, 2023 (GLOBE NEWSWIRE) -- The "Optic Neuritis Treatment Market - Growth, Trends, and Forecasts (2023 - 2028)" report has been added to ResearchAndMarkets.com's offering.The optic...
Transparency Market Research
Surgical Kits Market Surpass USD 40 billion by 2031, Expanding at a CAGR of 7% - Exclusive Report by Transparency Market Research
August 30, 2023 07:30 ET | Transparency Market Research
Wilmington, Delaware, United States, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global surgical kits market is projected to flourish at a CAGR of 7% from 2023 to 2031....